Elevated serum levels of anti‐Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome
Sezai Şahmay(Istanbul University-Cerrahpaşa), Hakan Seyisoğlu(Istanbul University), Begüm Aydoğan Mathyk(University of South Florida), Metehan İmamoğlu(Istanbul University), Yavuz Aydın(Istanbul University), Nil Atakul
Cited by 69
Related Papers
Serum AMH levels and insulin resistance in women with PCOS
|European Journal of Obstetrics & Gynecology and Reproductive Biology|2018|95
Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome
|European Journal of Obstetrics & Gynecology and Reproductive Biology|2013|86
Clinical characteristics and pregnancy outcomes of Syrian refugees: a case–control study in a tertiary care hospital in Istanbul, Turkey
|Archives of Gynecology and Obstetrics|2016|77
Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes
|Archives of Gynecology and Obstetrics|2011|57